Home LiteratureArticle Details
PMID: 10190898 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease.

The Journal of experimental medicine ·Vol. 189 ·No. 7 ·1999-04-05 ·Pages 1073-81

Zeng D, Lewis D, Dejbakhsh-Jones S, Lan F, García-Ojeda M, Sibley R, Strober S

Abstract

Sorted CD4(+) and CD8(+) T cells from the peripheral blood or bone marrow of donor C57BL/6 (H-2(b)) mice were tested for their capacity to induce graft-versus-host disease (GVHD) by injecting the cells, along with stringently T cell-depleted donor marrow cells, into lethally irradiated BALB/c (H-2(d)) host mice. The peripheral blood T cells were at least 30 times more potent than the marrow T cells in inducing lethal GVHD. As NK1.1(+) T cells represented <1% of all T cells in the blood and approximately 30% of T cells in the marrow, the capacity of sorted marrow NK1.1(-) CD4(+) and CD8(+) T cells to induce GVHD was tested. The latter cells had markedly increased potency, and adding back marrow NK1.1(+) T cells suppressed GVHD. The marrow NK1.1(+) T cells secreted high levels of both interferon gamma (IFN-gamma) and interleukin 4 (IL-4), and the NK1.1(-) T cells secreted high levels of IFN-gamma with little IL-4. Marrow NK1.1(+) T cells obtained from IL-4(-/-) rather than wild-type C57BL/6 donors not only failed to prevent GVHD but actually increased its severity. Together, these results demonstrate that GVHD is reciprocally regulated by the NK1.1(-) and NK1.1(+) T cell subsets via their differential production of cytokines.

MeSH Terms
Animals Bone Marrow/immunology Bone Marrow Transplantation/adverse effects CD4-Positive T-Lymphocytes/immunology,metabolism CD8-Positive T-Lymphocytes/immunology,metabolism Graft vs Host Disease/immunology,pathology H-2 Antigens/immunology Interferon-gamma/metabolism Interleukin-4/deficiency,genetics,metabolism Killer Cells, Natural/immunology,metabolism Male Mice Mice, Inbred BALB C Mice, Inbred C57BL Mice, Knockout Radiation Chimera T-Lymphocyte Subsets/immunology,metabolism,pathology
Chemicals
H-2 Antigens Interleukin-4 Interferon-gamma
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Zeng D
Department of Medicine, Division of Immunology and Rheumatology, Stanford, California 94305, USA.
Lewis D
Dejbakhsh-Jones S
Lan F
García-Ojeda M
Sibley R
Strober S
References (41)
41 references, click to expand
  1. In vitro and in vivo analysis of bone marrow-derived CD3+, CD4-, CD8-, NK1.1+ cell lines.
    Cell Immunol. 1990 Sep;129(2):478-93 PMID: 2143439
  2. Human bone marrow lymphocytes. I. Distribution of lymphocyte subpopulations in the bone marrow of normal individuals.
    J Clin Invest. 1975 Jul;56(1):98-110 PMID: 1079808
  3. Unusual T cell populations in adult murine bone marrow. Prevalence of CD3+CD4-CD8- and alpha beta TCR+NK1.1+ cells.
    J Immunol. 1990 Nov 15;145(10):3209-15 PMID: 1977798
  4. Graft-versus-host disease in experimental allogeneic bone marrow transplantation.
    Proc Soc Exp Biol Med. 1991 May;197(1):12-8 PMID: 2020668
  5. Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation.
    Transplantation. 1991 Jun;51(6):1197-203 PMID: 2048196
  6. Generation and analysis of interleukin-4 deficient mice.
    Science. 1991 Nov 1;254(5032):707-10 PMID: 1948049
  7. Studies of CD4- CD8- alpha beta bone marrow T cells with suppressor activity.
    J Immunol. 1992 Jan 15;148(2):373-80 PMID: 1309556
  8. Different subsets of T cells in the adult mouse bone marrow and spleen induce or suppress acute graft-versus-host disease.
    J Immunol. 1992 Aug 1;149(3):808-17 PMID: 1386094
  9. Cytokine production by mature and immature CD4-CD8- T cells. Alpha beta-T cell receptor+ CD4-CD8- T cells produce IL-4.
    J Immunol. 1992 Aug 15;149(4):1211-5 PMID: 1386860
  10. NK1.1+ CD4+ CD8- thymocytes with specific lymphokine secretion.
    Eur J Immunol. 1993 Jan;23(1):307-10 PMID: 8419184
  11. Interferon-gamma prevents graft-versus-host disease after allogeneic bone marrow transplantation in mice.
    J Immunol. 1993 Dec 1;151(11):6451-9 PMID: 8245478
  12. Cells of Th2 cytokine phenotype prevent LPS-induced lethality during murine graft-versus-host reaction. Regulation of cytokines and CD8+ lymphoid engraftment.
    J Immunol. 1994 Feb 1;152(3):1004-13 PMID: 7905495
  13. CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3.
    J Exp Med. 1994 Apr 1;179(4):1285-95 PMID: 7908323
  14. An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans.
    J Exp Med. 1994 Sep 1;180(3):1097-106 PMID: 7520467
  15. Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease.
    J Immunol. 1995 Jul 15;155(2):585-93 PMID: 7608537
  16. The role of purified CD8+ T cells in graft-versus-leukemia activity and engraftment after allogeneic bone marrow transplantation.
    Transplantation. 1995 Aug 27;60(4):355-61 PMID: 7652765
  17. Interleukin-12 inhibits murine graft-versus-host disease.
    Blood. 1995 Sep 15;86(6):2429-38 PMID: 7662991
  18. Predominant expression of invariant V alpha 14+ TCR alpha chain in NK1.1+ T cell populations.
    Int Immunol. 1995 Jul;7(7):1157-61 PMID: 8527413
  19. Double negative (CD4-CD8- alpha beta+) T cells which promote tolerance induction and regulate autoimmunity.
    Immunol Rev. 1996 Feb;149:217-30 PMID: 9005216
  20. Beta 2-microglobulin-dependent T cells are dispensable for allergen-induced T helper 2 responses.
    J Exp Med. 1996 Oct 1;184(4):1507-12 PMID: 8879221
  21. The immunopathophysiology of acute graft-versus-host-disease.
    Stem Cells. 1996 Sep;14(5):473-89 PMID: 8888489
  22. Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease.
    J Immunol. 1996 Dec 1;157(11):4811-21 PMID: 8943383
  23. Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse.
    Eur J Immunol. 1996 Dec;26(12):2989-98 PMID: 8977295
  24. Association between alphabetaTCR+CD4-CD8- T-cell deficiency and IDDM in NOD/Lt mice.
    Diabetes. 1997 Apr;46(4):572-82 PMID: 9075796
  25. Mouse CD1-specific NK1 T cells: development, specificity, and function.
    Annu Rev Immunol. 1997;15:535-62 PMID: 9143699
  26. Granulocyte colony-stimulating factor reduces the capacity of blood mononuclear cells to induce graft-versus-host disease: impact on blood progenitor cell transplantation.
    Blood. 1997 Jul 1;90(1):453-63 PMID: 9207483
  27. Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells.
    J Exp Med. 1997 Jul 7;186(1):109-20 PMID: 9207002
  28. alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.
    J Exp Med. 1998 Apr 6;187(7):1047-56 PMID: 9529321
  29. An alternate pathway for T cell development supported by the bone marrow microenvironment: recapitulation of thymic maturation.
    J Exp Med. 1998 Jun 1;187(11):1813-23 PMID: 9607922
  30. Murine graft-versus-host disease in an F1-hybrid model using IFN-gamma gene knockout donors.
    J Immunol. 1998 Jul 15;161(2):631-40 PMID: 9670937
  31. Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice.
    J Clin Invest. 1998 Nov 1;102(9):1742-8 PMID: 9802888
  32. Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12.
    J Clin Invest. 1998 Dec 15;102(12):2126-35 PMID: 9854048
  33. Thymus-dependent lymphocytes in human bone marrow.
    J Clin Invest. 1975 Dec;56(6):1491-8 PMID: 1081550
  34. Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow.
    J Exp Med. 1978 Dec 1;148(6):1687-98 PMID: 363972
  35. Bone marrow transplantation across major histocompatability barriers in mice. III. Treatment of donor grafts with monoclonal antibodies directed against Lyt determinants.
    J Immunol. 1982 Feb;128(2):871-5 PMID: 6172513
  36. The effect of peripheral lymphoid cells on the incidence of lethal graft versus host disease following allogeneic mouse bone marrow transplantation.
    J Surg Res. 1983 Feb;34(2):133-44 PMID: 6337303
  37. Predictive factors for acute graft-versus-host disease in patients transplanted with HLA-identical bone marrow.
    Blood. 1984 Jun;63(6):1265-70 PMID: 6372895
  38. Surface markers of T cells causing lethal graft-vs-host disease to class I vs class II H-2 differences.
    J Immunol. 1985 Nov;135(5):3004-10 PMID: 3876371
  39. T cell subsets and graft-versus-host disease.
    Transplantation. 1987 Sep;44(3):335-9 PMID: 2957834
  40. Prevention of graft-versus-host disease by ex vivo T cell depletion: reduction in graft failure with augmented total body irradiation.
    Leukemia. 1988 May;2(5):300-3 PMID: 3287016
  41. Relationship between differing volumes of bone marrow aspirates and their cellular composition.
    Bone Marrow Transplant. 1990 Aug;6(2):103-7 PMID: 2207448
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1999-04-05
Pages
1073-81
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2193016
Subset
IM
Grants
NHLBI NIH HHS · R01 HL58250 · United States
NHLBI NIH HHS · P01 HL057443 · United States
NIAID NIH HHS · R01 AI40093 · United States
NHLBI NIH HHS · R01 HL57443 · United States
NHLBI NIH HHS · R01 HL058250 · United States
NIAID NIH HHS · R01 AI040093 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com